Recro Pharma: 3Q Earnings Snapshot

November 8, 2019

MALVERN, Pa. (AP) _ Recro Pharma Inc. (REPH) on Friday reported a loss of $4.3 million in its third quarter.

On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 19 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.

The specialty pharmaceutical company posted revenue of $25.3 million in the period, which beat Street forecasts. Three analysts surveyed by Zacks expected $19.8 million.

Recro Pharma expects full-year revenue in the range of $98 million to $100 million.

Recro Pharma shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REPH at https://www.zacks.com/ap/REPH